Coupling factor 6 downregulates platelet endothelial cell adhesion molecule-1 via c-Src activation and acts as a proatherogenic molecule

Atherosclerosis

Volumn 200, Issue 1, 2008, Pages 45-50

  Kumagai, Akiko ^a   Osanai, Tomohiro ^a   Katoh, Chisato ^a   Tanaka, Makoto ^a   Tomita, Hirofumi ^a   Morimoto, Takeshi ^a   Murakami, Reiichi ^a   Magota, Koji ^b   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

Angiotensin; Endothelial function; Nitric oxide; Signal transduction; Vasoactive agents

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; ANGIOTENSIN II; APOCININ; CD31 ANTIGEN; COUPLING FACTOR 6; EFRAPEPTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; OXIDOREDUCTASE INHIBITOR; PROSTACYCLIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SERINE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ACIDIFICATION; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SHEAR STRESS;

ANGIOTENSIN II; ANTIGENS, CD31; AORTA; ATHEROSCLEROSIS; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIAL CELLS; HUMANS; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; NITRIC OXIDE; OXIDATIVE PHOSPHORYLATION COUPLING FACTORS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; UMBILICAL VEINS;

EID: 49749114387     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.010     Document Type: Article

References (22)

1. Osanai T., Kamada T., Fujiwara N., et al. A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneously hypertensive rats. J Biol Chem 273 (1998) 31778-31783
2. 0-ATPase from bovine heart mitochondria. Biochemistry 30 (1991) 5369-5378
3. Tanaka M., Osanai T., Murakami R., et al. Effect of vasoconstrictor coupling factor 6 on gene expression profile in human vascular endothelial cells: enhanced release of asymmetric dimethylarginine. J Hypertens 24 (2006) 489-497
4. Osanai T., Tanaka M., Kamada T., et al. Mitochondrial coupling factor 6 as a novel endogenous vasoconstrictor. J Clin Invest 108 (2001) 1023-1030
5. Osanai T., Magota K., Tanaka M., et al. Intracellualr signaling for vasoconstrictor coupling factor 6: Novel function of β-subunit of ATP synthase as receptor. Hypertension 46 (2005) 1140-1146
6. Minehata K., Mukouyama Y.S., Sekiguchi T., Hara T., and Miyajima A. Macrophage colony stimulating factor modulates the development of hematopoiesis by stimulating the differentiation of endothelial cells in the AGM region. Blood 99 (2002) 2360-2368
7. Schimmenti L.A., Yan H.C., Madri J.A., and Albelda S.M. Platelet endothelial cell adhesion molecule, PECAM-1, modulates cell migration. J Cell Physiol 153 (1992) 417-428
8. Tzima E., Irani-Tehrani M., Kiosses W.B., et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437 (2005) 426-431
9. Wei H., Fang L., Song J., and Chatterjee S. Statin-inhibited endothelial permeability could be associated with its effect on PECAM-1 in endothelial cells. FEBS Lett 579 (2005) 1272-1278
10. Malek A., and Izumo S. Physiological fluid shear stress causes downregulation of endothelin1 mRNA in bovine aortic endothelium. Am J Physiol Cell Physiol 263 (1992) C389-C396
11. Fujiwara N., Osanai T., Kamada T., et al. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension. Modulation of nitric oxide synthesis by salt intake. Circulation 101 (2000) 856-861
12. Ward J.P.T., Knock G.A., Snetkov V.A., and Aaronson P.I. Protein kinases in vascular smooth muscle tone-role in the pulmonary vasculature and hypoxic pulmonary vasoconstriction. Pharmacol Therapeut 104 (2004) 207-231
13. Barker R.J., Price R.L., and Gourdie R.G. Increased association of ZO-1 with connexin43 during remodeling of cardiac gap junctions. Circ Res 90 (2002) 317-324
14. Almendro N., bellon T., Rius C., et al. Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue-specific expression. Structural and functional characterization. J Immunol 157 (1996) 5411-5421
15. Fulton D., Gratton J.P., and Sessa W.C. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?. J Pharmacol Exp Ther 299 (2001) 818-824
16. Fleming I., Fisslthaler B., Dixit M., and Busse R. Role of PECAM-1 in the shear-stress-induced activation of Akt and the endotehlial nitric oxide synthase (eNOS) in endothelial cells. J Cell Sci 118 (2005) 4103-4111
17. Osanai T., Sasaki S., Kamada T., et al. Circulating coupling factor 6 in human hypertension: role of reactive oxygen species. J Hypertens 21 (2003) 2323-2328
18. Osanai T., Nakamura M., Sasaki S., et al. Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease. Kidney Int 64 (2003) 2291-2297
19. Li X.L., Xing Q.C., Dong B., et al. Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus. Int J Cardiol 117 (2007) 411-412
20. Osanai T., Okada S., Sirato K., et al. Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and released by shear stress. Circulation 104 (2001) 3132-3136
21. Sasaki S., Osanai T., Tomita H., et al. Tumor necrosis factor α as an endogenous stimulator for circulating coupling factor 6. Cardiovasc Res 62 (2004) 578-586
22. 2 inhibit shear-induced coupling factor 6 release in endothelial cells. Cardiovasc Res 67 (2005) 134-141